The Therapeutic Goods Advertising Code (the Code) ensures that the marketing and advertising of therapeutic goods is conducted in a manner that promotes the quality use of the product, is socially responsible and does not mislead or deceive the consumer.

The Therapeutic Goods Administration administers the Code.

Current version of the Code

The Therapeutic Goods Advertising Code (No.2) 2018 took effect on 1 January 2019 and is available from the Federal Register of Legislation.

Information about the changeover to the 2018 Code, including which code is applied in the consideration of advertising approvals and complaints, is available from Changeover to the new Therapeutic Goods Advertising Code. Information about our approach to enforcement discretion during 2019 is available from the Therapeutic goods advertising: Update 29 October 2018.

Code guidance

The Therapeutic Goods Advertising Code 2018 (No. 2) is supported by the guidance document; Complying with the Therapeutic Advertising Code (No. 2) 2018

Previous versions of the TGAC

• Therapeutic Goods Advertising Code 2015
• Therapeutic Goods Advertising Code 2007
• Therapeutic Goods Advertising Code 2006
• Therapeutic Goods Advertising Code 2005

Amendments to the TGAC

Information about amendments to the Code over 5 years old can be found in the TGA Internet site archive.